GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Basic Sciences/unstable mitochondrial DNA mutations in HCC at single-cell resolution
101

unstable mitochondrial DNA mutations in HCC at single-cell resolution

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated February 1, 2025

Unstable mitochondrial DNA (mtDNA) mutations in hepatocellular carcinoma (HCC) were studied using a novel sequencing platform called single-cell capture-based mtDNA sequencing (sc-CAMS). This method allowed researchers to analyze mtDNA mutations at single-cell resolution, providing detailed insights into tumor heterogeneity. In the study, 1,641 single cells from 11 HCC patients and 528 cells from two xenograft mouse models were analyzed, revealing two types of mtDNA mutations: stable mutations (consistent heteroplasmy across cells) and unstable mutations (high variability in heteroplasmy among cells).

Unstable mtDNA mutations were strongly linked to intratumor heterogeneity (ITH), a hallmark of aggressive tumors. Tumors with high levels of unstable mutations exhibited proliferative and aggressive clinical features. These mutations evolved bidirectionally during tumor progression, undergoing both positive selection (expansion) and negative selection (elimination), showcasing the dynamic nature of tumor evolution. Through evolutionary reconstruction, researchers demonstrated that HCC follows both linear and branched progression models, indicating multiple evolutionary paths within the same tumor.

The study also visualized the spatiotemporal evolution of mtDNA mutations in patient-derived xenografts and multifocal tumor regions, showing how these mutations influence metabolic homeostasis, tumor evolution, and therapeutic resistance. Unstable mtDNA mutations could serve as biomarkers for tumor prognosis, stratification, and targeted therapies in HCC.

Related Q&A

102

Role of TREM2 in Pancreatic Ductal Adenocarcinoma

Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) is a receptor found on macrophages and other immune cells, playing a critical role in immune regulation and inflammation. In...

103

Elevated FBXO45 and metastatic HCC

Elevated FBXO45 expression has been identified as a critical driver of metastasis in hepatocellular carcinoma (HCC), particularly in cases involving TP53 mutations. Below is a detailed explanation of...

104

Mechanocrine signaling, Yap, HB-EGF, and liver regeneration.

Mechanocrine signaling, Yap (Yes-associated protein), HB-EGF (heparin-binding EGF-like growth factor), and liver regeneration are interconnected elements that play pivotal roles in the process of liver regrowth, particularly after...

105

Stretch-induced hepatic endothelial mechanocrine and hepatocyte proliferation

The study focuses on how mechanical stretching of liver sinusoidal endothelial cells (LSECs) after partial hepatectomy (surgical removal of a part of the liver) triggers liver regeneration by...

106

STARD1 promotes cholestatic liver injury and disease progression

Yes, STARD1 (Steroidogenic Acute Regulatory Protein D1) plays a key role in promoting cholestatic liver injury and disease progression. Cholestatic liver diseases occur when bile acids, which are...

107

Intestinal Gas and its role in SIBO

Intestinal gas plays a significant role in both normal gastrointestinal function and in pathological conditions such as Small Intestinal Bacterial Overgrowth (SIBO). To fully understand its implications in...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer